Indeed, the activities of ERAP for immune escape of cancer cells have been revealed [24, 25], suggesting the poor survival of OSCC patients with elevated level of ERAP2 may result from the ERAP2-associated immune evasion. The gene discussed is ERAP2; the disease is cancer.